Partner Content Partner Content WHO's Senior Advisor to speak at 21st Annual Superbugs &... WHO to speak at 21st Superbugs & Superdrugs 2019
News Merck to file for new use for antibiotic Zerbaxa Antibiotic matched standard of care in phase 3 trial
Partner Content Partner Content SMi’s Exclusive Interview with MedImmune Principal Scientist... An exclusive interview with Dr. Antonio DiGiandomenico, Principal Scientist, MedImmune has been released
News Novartis to cease antibiotic R&D despite superbug threat Yet another big pharma quits antibiotics research
Partner Content Partner Content Superbugs & Superdrugs USA Conference returns to New Jer... Superbugs & Superdrugs USA Conference, Nov 2018
News Cut use of antibiotics in nursing homes, pharmacists say Pharmacists could train staff to cut prescriptions
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
